Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,749 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Systemic Codelivery of Thymoquinone and Doxorubicin by Targeted Mesoporous Silica Nanoparticle Sensitizes Doxorubicin-Resistant Breast Cancer by Interfering between the MDR1/P-gp and miR 298 Crosstalk.
Bhattacharjee M, Ghosh A, Das S, Sarker S, Bhattacharya S, Das A, Ghosh S, Chattopadhyay S, Ghosh S, Adhikary A. Bhattacharjee M, et al. Among authors: ghosh s, ghosh a. ACS Biomater Sci Eng. 2024 Oct 14;10(10):6314-6331. doi: 10.1021/acsbiomaterials.4c01081. Epub 2024 Sep 16. ACS Biomater Sci Eng. 2024. PMID: 39285678
Delivery of novel coumarin-dihydropyrimidinone conjugates through mixed polymeric nanoparticles to potentiate therapeutic efficacy against triple-negative breast cancer.
Ghosh A, Upadhyay P, Sarker S, Das S, Bhattacharjee M, Bhattacharya S, Ahir M, Guria S, Gupta P, Chattopadhyay S, Ghosh S, Adhikari S, Adhikary A. Ghosh A, et al. Among authors: ghosh s. Biomater Sci. 2021 Aug 21;9(16):5665-5690. doi: 10.1039/d1bm00424g. Epub 2021 Jul 14. Biomater Sci. 2021. PMID: 34259681
Delivery of gefitinib in synergism with thymoquinone via transferrin-conjugated nanoparticle sensitizes gefitinib-resistant non-small cell lung carcinoma to control metastasis and stemness.
Upadhyay P, Ghosh A, Basu A, Pranati PA, Gupta P, Das S, Sarker S, Bhattacharjee M, Bhattacharya S, Ghosh S, Chattopadhyay S, Adhikary A. Upadhyay P, et al. Among authors: ghosh s, ghosh a. Biomater Sci. 2021 Dec 7;9(24):8285-8312. doi: 10.1039/d1bm01148k. Biomater Sci. 2021. PMID: 34766965
Tailored-CuO-nanowire decorated with folic acid mediated coupling of the mitochondrial-ROS generation and miR425-PTEN axis in furnishing potent anti-cancer activity in human triple negative breast carcinoma cells.
Ahir M, Bhattacharya S, Karmakar S, Mukhopadhyay A, Mukherjee S, Ghosh S, Chattopadhyay S, Patra P, Adhikary A. Ahir M, et al. Among authors: ghosh s. Biomaterials. 2016 Jan;76:115-32. doi: 10.1016/j.biomaterials.2015.10.044. Epub 2015 Oct 21. Biomaterials. 2016. PMID: 26520043
Delivery of thymoquinone through hyaluronic acid-decorated mixed Pluronic® nanoparticles to attenuate angiogenesis and metastasis of triple-negative breast cancer.
Bhattacharya S, Ghosh A, Maiti S, Ahir M, Debnath GH, Gupta P, Bhattacharjee M, Ghosh S, Chattopadhyay S, Mukherjee P, Adhikary A. Bhattacharya S, et al. Among authors: ghosh s, ghosh a. J Control Release. 2020 Jun 10;322:357-374. doi: 10.1016/j.jconrel.2020.03.033. Epub 2020 Mar 31. J Control Release. 2020. PMID: 32243981
Combinatorial therapy of Thymoquinone and Emodin synergistically enhances apoptosis, attenuates cell migration and reduces stemness efficiently in breast cancer.
Bhattacharjee M, Upadhyay P, Sarker S, Basu A, Das S, Ghosh A, Ghosh S, Adhikary A. Bhattacharjee M, et al. Among authors: ghosh s, ghosh a. Biochim Biophys Acta Gen Subj. 2020 Nov;1864(11):129695. doi: 10.1016/j.bbagen.2020.129695. Epub 2020 Jul 29. Biochim Biophys Acta Gen Subj. 2020. PMID: 32735937
13,749 results
You have reached the last available page of results. Please see the User Guide for more information.